High Tower Advisors, LLC 23and Me Holding Co. Transaction History

High Tower Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.36 - $0.61 $17 - $29	-49 Reduced 0.06%	86,956 $33,000
Q1 2024 May 06, 2024	BUY	$0.4 - $0.91 $3,582 - $8,150	8,957 Added 11.48%	87,005 $46,000
Q4 2023 Feb 12, 2024	SELL	$0.71 - $0.97 $687 - $939	-969 Reduced 1.23%	78,048 $71,000
Q3 2023 Nov 08, 2023	BUY	$0.96 - $2.01 $65,426 - $136,987	68,153 Added 627.33%	79,017 $77,000
Q2 2023 Aug 14, 2023	BUY	$1.59 - $2.29 $17,273 - $24,878	10,864 New	10,864 $19,000
Q2 2022 Aug 10, 2022	SELL	$2.19 - $3.98 $24,317 - $44,193	-11,104 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$3.28 - $7.12 $10,243 - $22,235	-3,123 Reduced 21.95%	11,104 $41,000
Q4 2021 Feb 10, 2022	SELL	$6.55 - $13.25 $57,325 - $115,964	-8,752 Reduced 38.09%	14,227 $93,000
Q3 2021 Nov 12, 2021	SELL	$7.29 - $11.0 $23,021 - $34,738	-3,158 Reduced 12.08%	22,979 $206,000
Q2 2021 Aug 06, 2021	BUY	$9.87 - $13.32 $257,972 - $348,144	26,137 New	26,137 $307,000

117

85M

404K

292K

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $992M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.